AAAAAA

   
Results: 1-14 |
Results: 14
COMPARISON OF 10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID(DOTA)-PEPTIDE-CHL6, A NOVEL IMMUNOCONJUGATE WITH CATABOLIZABLE LINKER, TO 2-IMINOTHIOLANE-2 [P-(BROMOACETAMIDO)BENZYL]-DOTA-CHL6 IN BREAST-CANCER XENOGRAFTS
Authors: DENARDO GL KROGER LA MEARES CF RICHMAN CM SALAKO Q SHEN S LAMBORN KR PETERSON JJ MIERS LA ZHONG GR DENARDO SJ
Citation: Gl. Denardo et al., COMPARISON OF 10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID(DOTA)-PEPTIDE-CHL6, A NOVEL IMMUNOCONJUGATE WITH CATABOLIZABLE LINKER, TO 2-IMINOTHIOLANE-2 [P-(BROMOACETAMIDO)BENZYL]-DOTA-CHL6 IN BREAST-CANCER XENOGRAFTS, Clinical cancer research, 4(10), 1998, pp. 2483-2490
EVIDENCE IN MICE AND PATIENTS THAT A NOVEL PEPTIDE LINKED Y-90 DOTA-CHIMERIC L6 IMMUNOCONJUGATE DECREASED HEPATIC RADIATION-DOSE
Authors: DENARDO SJ SHEN S KROGER LA MIERS LA RICHMAN CM KUKIS DL SALAKO Q MEARES CF DENARDO GL
Citation: Sj. Denardo et al., EVIDENCE IN MICE AND PATIENTS THAT A NOVEL PEPTIDE LINKED Y-90 DOTA-CHIMERIC L6 IMMUNOCONJUGATE DECREASED HEPATIC RADIATION-DOSE, The Journal of nuclear medicine, 39(5), 1998, pp. 833-833
SYNERGISTIC THERAPY FOR BREAST-CANCER - DEVELOPMENT OF A CLINICAL PROTOCOL FOR RIT AND TAXOL BASED ON CURATIVE THERAPY OF XENOGRAFTED TUMORS AND Y-90 CHL6 PATIENT DOSIMETRY
Authors: DENARDO SJ RICHMAN CM KUKIS DL SHEN S LAMBORN KR MIERS LA KROGER LA DENARDO GL
Citation: Sj. Denardo et al., SYNERGISTIC THERAPY FOR BREAST-CANCER - DEVELOPMENT OF A CLINICAL PROTOCOL FOR RIT AND TAXOL BASED ON CURATIVE THERAPY OF XENOGRAFTED TUMORS AND Y-90 CHL6 PATIENT DOSIMETRY, The Journal of nuclear medicine, 39(5), 1998, pp. 1083-1083
YTTRIUM-90 INDIUM-111-DOTA-PEPTIDE-CHIMERIC L6 - PHARMACOKINETICS, DOSIMETRY AND INITIAL RESULTS IN PATIENTS WITH INCURABLE BREAST-CANCER/
Authors: DENARDO SJ RICHMAN CM GOLDSTEIN DS SHEN S SALAKO Q KUKIS DL MEARES CF YUAN A WELBORN JL DENARDO GL
Citation: Sj. Denardo et al., YTTRIUM-90 INDIUM-111-DOTA-PEPTIDE-CHIMERIC L6 - PHARMACOKINETICS, DOSIMETRY AND INITIAL RESULTS IN PATIENTS WITH INCURABLE BREAST-CANCER/, Anticancer research, 17(3B), 1997, pp. 1735-1744
RADIOIMMUNOTHERAPY FOR ADVANCED BREAST-CANCER USING I-131 CHL6 ANTIBODY
Authors: DENARDO SJ OGRADY LF RICHMAN CM GOLDSTEIN DS ODONNELL RT DENARDO DA KROGER LA LAMBORN KR HELLSTROM KE HELLSTROM I DENARDO GL
Citation: Sj. Denardo et al., RADIOIMMUNOTHERAPY FOR ADVANCED BREAST-CANCER USING I-131 CHL6 ANTIBODY, Anticancer research, 17(3B), 1997, pp. 1745-1751
RADIOIMMUNOTHERAPY FOR BREAST-CANCER USING INDIUM-111 YTTRIUM-90 BRE-3 - RESULTS OF A PHASE-I CLINICAL-TRIAL/
Authors: DENARDO SJ KRAMER EL ODONNELL RT RICHMAN CM SALAKO QA SHEN S NOZ M GLENN SD CERIANI RL DENARDO GL
Citation: Sj. Denardo et al., RADIOIMMUNOTHERAPY FOR BREAST-CANCER USING INDIUM-111 YTTRIUM-90 BRE-3 - RESULTS OF A PHASE-I CLINICAL-TRIAL/, The Journal of nuclear medicine, 38(8), 1997, pp. 1180-1185
IMPORTANCE OF TEMPORAL RELATIONSHIPS IN COMBINED-MODALITY RADIOIMMUNOTHERAPY OF BREAST-CARCINOMA
Authors: DENARDO SJ KROGER LA LAMBORN KR MIERS LA ODONNELL RT KUKIS DL RICHMAN CM DENARDO GL
Citation: Sj. Denardo et al., IMPORTANCE OF TEMPORAL RELATIONSHIPS IN COMBINED-MODALITY RADIOIMMUNOTHERAPY OF BREAST-CARCINOMA, Cancer, 80(12), 1997, pp. 2583-2590
PERIPHERAL-BLOOD STEM-CELL MOBILIZATION FOR HEMATOPOIETIC SUPPORT OF RADIOIMMUNOTHERAPY IN PATIENTS WITH BREAST-CARCINOMA
Authors: RICHMAN CM SCHUERMANN TC WUN T MALIK R ODONNELL RT DENARDO GL DENARDO SJ
Citation: Cm. Richman et al., PERIPHERAL-BLOOD STEM-CELL MOBILIZATION FOR HEMATOPOIETIC SUPPORT OF RADIOIMMUNOTHERAPY IN PATIENTS WITH BREAST-CARCINOMA, Cancer, 80(12), 1997, pp. 2728-2732
EXAMINATION OF THE CD34- CELL-POPULATION IN G-CSF-MOBILIZED PERIPHERAL-BLOOD(CD38)
Authors: LAGARIAS DM PAGLIERONI TG RICHMAN CM
Citation: Dm. Lagarias et al., EXAMINATION OF THE CD34- CELL-POPULATION IN G-CSF-MOBILIZED PERIPHERAL-BLOOD(CD38), Blood, 90(10), 1997, pp. 1643-1643
A MOUSE MODEL FOR HUMAN CONGENITAL ERYTHROPOIETIC PORPHYRIA
Authors: PIMSTONE NR SAICHEUR T HESS E SCHUERMANN T LARKIN E DESNICK RJ MUKERJI SK RICHMAN CM POWELL JR TROUTT T
Citation: Nr. Pimstone et al., A MOUSE MODEL FOR HUMAN CONGENITAL ERYTHROPOIETIC PORPHYRIA, Hepatology, 23(1), 1996, pp. 305-305
RADIOIMMUNOTHERAPY FOR BREAST-CANCER USING ESCALATING FRACTIONATED DOSES OF I-131-LABELED CHIMERIC L6 ANTIBODY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSFUSIONS
Authors: RICHMAN CM DENARDO SJ OGRADY LF DENARDO GL
Citation: Cm. Richman et al., RADIOIMMUNOTHERAPY FOR BREAST-CANCER USING ESCALATING FRACTIONATED DOSES OF I-131-LABELED CHIMERIC L6 ANTIBODY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSFUSIONS, Cancer research, 55(23), 1995, pp. 5916-5920
SEQUENTIAL TRANSPLANTS USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS
Authors: GHALIE R RICHMAN CM BENDER JG MCLEOD BC LEE W CZYZEWSKI A MANSON S COBLEIGH MA REED S PIERRE R GEORGE S KAIZER H
Citation: R. Ghalie et al., SEQUENTIAL TRANSPLANTS USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Journal of clinical apheresis, 9(3), 1994, pp. 176-182
TREATMENT OF METASTATIC BREAST-CANCER WITH A SPLIT-COURSE HIGH-DOSE CHEMOTHERAPY REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: GHALIE R RICHMAN CM ADLER SS COBLEIGH MA KORENBLIT AD MANSON SD MCLEOD BC TAYLOR SG VALENTINO LA WOLTER J KAIZER H
Citation: R. Ghalie et al., TREATMENT OF METASTATIC BREAST-CANCER WITH A SPLIT-COURSE HIGH-DOSE CHEMOTHERAPY REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 12(2), 1994, pp. 342-346
RADIOIMMUNOTHERAPY OF BREAST-CANCER WITH Y-90 N-111 BRE-3 - CURRENT CLINICAL-RESULTS AND THERAPEUTIC POTENTIAL/
Authors: DENARDO SJ KRAMER EL RICHMAN CM SALAKO QA PEREZ EA OGRADY LF RIPPON MB GLENN SD BUTCHKO GM COUTO JC CERIANI RL DENARDO GL
Citation: Sj. Denardo et al., RADIOIMMUNOTHERAPY OF BREAST-CANCER WITH Y-90 N-111 BRE-3 - CURRENT CLINICAL-RESULTS AND THERAPEUTIC POTENTIAL/, The Journal of nuclear medicine, 34(5), 1993, pp. 53-53
Risultati: 1-14 |